2022-12-01 2023-11-30 false Capium Accounts Production 1.1 09326740 2022-12-01 2023-11-30 09326740 bus:FullAccounts 2022-12-01 2023-11-30 09326740 bus:Micro-entities 2022-12-01 2023-11-30 09326740 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 09326740 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 09326740 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 09326740 2022-12-01 2023-11-30 09326740 2023-11-30 09326740 bus:RegisteredOffice 2022-12-01 2023-11-30 09326740 core:WithinOneYear 2023-11-30 09326740 core:AfterOneYear 2023-11-30 09326740 1 2022-12-01 2023-11-30 09326740 bus:Director1 2022-12-01 2023-11-30 09326740 bus:Director1 2023-11-30 09326740 bus:Director1 2021-12-01 2022-11-30 09326740 bus:Director2 2022-12-01 2023-11-30 09326740 bus:Director2 2023-11-30 09326740 bus:Director2 2021-12-01 2022-11-30 09326740 2021-12-01 09326740 bus:LeadAgentIfApplicable 2022-12-01 2023-11-30 09326740 2021-12-01 2022-11-30 09326740 2022-11-30 09326740 core:WithinOneYear 2022-11-30 09326740 core:AfterOneYear 2022-11-30 09326740 bus:EntityAccountantsOrAuditors 2021-12-01 2022-11-30 09326740 bus:OrdinaryShareClass1 2022-12-01 2023-11-30 09326740 bus:OrdinaryShareClass1 2023-11-30 09326740 bus:OrdinaryShareClass1 2021-12-01 2022-11-30 09326740 bus:OrdinaryShareClass1 2022-11-30 09326740 core:ComputerEquipment 2022-12-01 2023-11-30 09326740 core:ComputerEquipment 2023-11-30 09326740 core:ComputerEquipment 2022-11-30 09326740 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-11-30 09326740 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2022-11-30 09326740 core:CostValuation core:Non-currentFinancialInstruments 2023-11-30 09326740 core:CostValuation core:Non-currentFinancialInstruments 2022-11-30 09326740 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2023-11-30 09326740 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2023-11-30 09326740 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2023-11-30 09326740 core:Non-currentFinancialInstruments 2023-11-30 09326740 core:Non-currentFinancialInstruments 2022-11-30 iso4217:GBP xbrli:shares xbrli:pure
Reports Dated : 24/02/2025 Registered Number: 09326740
England and Wales

 

 

 

MEDEXX MEDICAL LTD


Unaudited Financial Statements
 


Period of accounts

Start date: 01 December 2022

End date: 30 November 2023
Directors Modupe Oluwafunmilayo AJAYI
Taiwo Olaoluwa Ayodele AJAYI
Registered Number 09326740
Registered Office 81 BROMPTON FARM RD
STROOD ROCHESTER
ME2 3RF
Accountants J and Co. Accountants
85 Great Portland Street
First Floor
LONDON
United Kingdom
W1W 7LT
1
Director's report and financial statements
The directors present his/her/their report and accounts for the year ended 30 November 2023.
Principal activities
The principal activity of the company in the period under review was:
Medical and educational services.

Directors
The directors who served the company throughout the year were as follows:
Modupe Oluwafunmilayo AJAYI
Taiwo Olaoluwa Ayodele AJAYI
Political and charitable donations
Charitable donations during the year amounted to £1,480 (2022 - £2,770). No contributions to political organizations were made during the year.

Statement of directors' responsibilities
The directors are responsible for preparing the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). The financial statements are required by law to give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:
  • select suitable accounting policies and then apply them consistently
  • make judgements and estimates that are reasonable and prudent
  • state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements
  • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.


The directors are responsible for keeping proper accounting records that disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The directors are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

This report was approved by the board and signed on its behalf by:


----------------------------------
Taiwo Olaoluwa Ayodele AJAYI
Director

Date approved: 24 February 2025
2
  2023   2022
    £ £   £ £
Fixed assets   34      45 
Current assets 1,994      2,858   
Prepayments and accrued income 20,000       
Creditors: amount falling due within one year (42,851)     (33,946)  
Net current assets   (20,857)     (31,088)
Total assets less current liabilities   (20,823)     (31,043)
Accruals and deferred income   (800)     (1,100)
Net assets   (21,623)     (32,143)
 

         
Capital and reserves   (21,623)     (32,143)
 
NOTES TO THE ACCOUNTS

General Information
MEDEXX MEDICAL LTD is a private company, limited by shares, registered in England and Wales, registration number 09326740, registration address 81 BROMPTON FARM RD, STROOD ROCHESTER, ME2 3RF.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
2.

Average number of employees

Average number of employees during the year was 1 (2022 : 1).


For the year ended 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 24 February 2025 and were signed on its behalf by:


--------------------------------
Taiwo Olaoluwa Ayodele AJAYI
Director
3